Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clovis Oncology Inc (NQ: CLVS )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clovis Oncology Inc

< Previous 1 2 3 4 5 6 7 Next >
12 Health Care Stocks Moving In Monday's Intraday Session
  
Via Benzinga
Why Is Clovis Oncology (CLVS) Stock Down 10% Today?
Clovis Oncology is in the red today after a lackluster earnings report. CLVS stock is down 10% on missed profit and revenue. 
Via InvestorPlace
Clovis Oncology Needs Funding To Continue As Going Concern Beyond Early Next Year
Clovis Oncology Inc (NASDAQ: CLVS) said  
Via Benzinga
Recap: Clovis Oncology Q2 Earnings
  Clovis Oncology (NASDAQ:CLVS) reported its Q2 earnings results on Monday, August 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Clovis Oncology Announces Second Quarter 2022 Operating Results and Provides Update on Clinical Development Programs
From Clovis Oncology, Inc.
Via Business Wire
Why Is Clovis Oncology (CLVS) Stock in the Spotlight Today?
Clovis (CLVS) stock is on investors' radars as its shareholder meeting is resuming today. The company is seeking approval for a reverse split. 
Via InvestorPlace
7 Penny Stocks to Buy Before the Bull Market Returns
With stocks in the doldrums, the time to take a look at these 7 penny stocks to buy before the bull market returns. 
Via InvestorPlace
CORRECTING and REPLACING Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8
From Clovis Oncology, Inc.
Via Business Wire
Clovis Oncology (CLVS) Stock Pops 7% on Supply Agreement
CLVS stock is rallying 7% after Clovis Oncology made a major deal with NorthStar Medical. Takeover speculation has swirled around Clovis. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday! 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Most Active Equity Options For Midday - Monday, July 11
Here are the most active equity options for midday. 
Via Talk Markets
Is Clovis Oncology (CLVS) Stock the Next Big Squeeze?
Clovis Oncology is skyrocketing after being flagged as a top gamma squeeze candidate. Here's why investors should be watching CLVS stock. 
Via InvestorPlace
Dow Rises 75 Points; Kura Sushi USA Shares Spike Higher
U.S. stocks traded slightly higher toward the end of trading as investors digested the recent jobs report for the month of June. 
Via Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
  
Via Benzinga
Most Active Equity Options For Midday - Friday, July 8
Here are the most active equity options for midday. 
Via Talk Markets
Dow Turns Positive After Better-Than-Expected Jobs Report
U.S. stocks turned higher midway through as investors digested the recent jobs report for the month of June. 
Via Benzinga
Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares surged 75.7% to $0.2812 after the company's Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100. 
Via Benzinga
Why U.S. Stocks Are Trading Lower Despite Upbeat Nonfarm Payrolls Report
U.S. stocks traded lower this morning following the release of jobs report for the month of June. 
Via Benzinga
Clovis Oncology (CLVS) Stock Gains as Shareholders Reject Reverse Stock Split
Clovis' (CLVS) shareholders decided to reject a proposal for a reverse split of CLVS stock. Clovis' shares appear to be rising on the news. 
Via InvestorPlace
Twitter And 20 Stocks Moving Premarket
Gainers Seritage Growth Properties (NYSE: SRG) rose 35.7% to $8.25 in pre-market trading after gaining around 10% on Thursday. Seritage Growth Properties filed its preliminary proxy materials with the... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers 
Via Benzinga
Why Are Meme Stocks AMC and GME Roaring Higher Today?
Meme stocks are a hot topic among traders on Thursday as investors react to recent news from AMC Entertainment (AMC) and GameStop (GME). 
Via InvestorPlace
Why U.S. Stocks Are Trading Higher After Rise In Jobless Claims
U.S. stocks traded higher this morning, following the release of data on initial jobless claims. 
Via Benzinga
The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
FDA's Recommendation Before Clovis Submits Rubraca Application For Ovarian Cancer
Earlier this month, Clovis Oncology Inc (NASDAQ: CLVS) had a Type A meeting with the FDA to discuss its plans for a supplemental marketing application for Rubraca (Rucaparib) as a first-line... 
Via Benzinga
Is Evofem Biosciences (EVFM) Stock the Next Big Squeeze?
Fintel has ranked Evofem Biosciences as the next top gamma squeeze. Will Meade noticed. Here's what this means for EVFM stock. 
Via InvestorPlace
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday. 
Via Benzinga
Most Active Equity Options For Midday - Tuesday, July 5
Here are the most active equity options for midday. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.